{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "EGFR",
        "Protein_Change": {
          "ref": "L",
          "alt": "R",
          "position": "858"
        },
        "variant_string_id": "EGFR L858R"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism.",
          "extracted_paper_info": "The paper discusses how EGFR mutations contribute to lung cancer development through activation of signaling pathways.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field.",
          "extracted_paper_info": "The paper uses kinase activity assays which are commonly used to study the effects of EGFR mutations on signaling.",
          "judgment": "Yes",
          "reasoning": "Kinase activity assays effectively model the disease pathogenesis.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays.",
          "extracted_paper_info": "The paper includes basic controls such as wild-type EGFR and known loss-of-function mutants, as well as multiple replicates for each experiment.",
          "judgment": "Yes",
          "reasoning": "Basic controls and replicates were included for the assays.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        }
      ]
    }
  ]
}